International Journal of Antimicrobial Agents

Article	Citations
Title Page & Editorial Board	88
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	78
Cystathionine γ-lyase: The Achilles heel of bacterial defense systems	73
A contribution on the fosfomycin mechanism of resistance in multidrug-resistant organisms	61
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole gen	60
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	57
Erratum to “Empiric antibiotic protocols for cancer patients with neutropenia: a single–center study of treatment efficacy and mortality in patients with bacteremia” [International Journal of Antimicr	57
Daily fluid intake as a novel covariate affecting the population pharmacokinetics of polymyxin B in patients with sepsis	57
Title Page & Editorial Board	55
Characterisation of the genome of a Klebsiella pneumoniae clinical strain carrying a novel KPC-205 variant associated with resistance to ceftazidime/avibactam and cefiderocol	55
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	51
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	47
Mycobacterium species on the cutaneous microbiome of very preterm neonates admitted to the NICU in a tertiary health care hospital	45
Heterogeneous Vancomycin Intermediate Staphylococcus aureus infections in tertiary care hospitals in Coastal Karnataka, India	45
Emergence of intrinsically resistant Gram-negative bacteria with an environmental primary habitat	43
Antimicrobial therapy for carbapenem-resistant gram-negative bacteria	43
Vaccines against SARS-COV-2	42
In vitro activity of β-lactam-β-lactam enhancer combination, cefepime/zidebactam (WCK 5222, FEP/ZID) against multi-clonal, colistin-resistant Klebsiella pneumoniae	41
Severe Salmonella enteritidis infection complicated with colonic perforations and abdominal cocoon	41
Hospitalization decision model for COVID-19 patients with comorbidities	39
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	38
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	36
Efficacy of clofazimine-containing regimens for treatment of Mycobacterium avium complex–pulmonary disease in patients unsuitable for standard treatment regimen	35
Development of a new antibiotic-induced dysbiosis model of the canine colonic microbiota	35
Large-scale comparative analysis reveals phylogenomic preference of blaNDM-1 and blaKPC-2 transmission among Klebsiella pneumoniae	35

Global prevalence of fosfomycin resistance genes fosA and fosB in multidrug-resistant bacteria	33
Dysbiosis of the gut microbiota is associated with in-hospital mortality in patients with antibiotic-associated diarrhoea: A metagenomic analysis	33
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university ho	33
Effectiveness of rifampicin combination therapy for orthopaedic implant-related infections: A systematic review and meta-analysis	32
Antifungal activity and potential mechanism of action of caspofungin in combination with ribavirin against Candida albicans	32
Lopinavir and ritonavir act synergistically with azoles against Candida auris in vitro and in a mouse model of disseminated candidiasis	32
Daptomycin non-susceptible Staphylococcus argenteus isolated from a patient without prior antibiotic exposure	30
Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy	29
Immunomodulator AS101 restores colistin susceptibility of clinical colistin-resistant Escherichia coli and Klebsiella pneumoniae in vitro and in vivo	29
Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia	29
Enhanced Targeted NGS Assay for Comprehensive Diagnosis in Tuberculosis and Drug-Resistant Tuberculosis Patients	28
Antibiotic spectrum index as an antimicrobial stewardship tool in paediatric intensive care settings	28
A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting	27
Colistin- and tigecycline-resistant CTX-M-14-producing Salmonella enterica serovar Kentucky ST198 from retail chicken meat, China	26
Antibiotic resistance in Enterobacter hormaechei	26
The New Delhi metallo-β-lactamase-1 biosensor rapidly and accurately detected antibiotic plasma concentrations in cefuroxime-treated patients	26
Extended infusion improves meropenem and piperacillin/tazobactam effectiveness in septic burn patients with normal renal by applying pharmacokinetics-pharmacodynamics approach	25
Resistance profiling and molecular characterization of methicillin-resistant Staphylococcus pseudintermedius isolated from dogs and cats	25
Psychological effects of paramedics by experience of managing COVID-19 patients	25
How I treat CMV infection in high-risk pediatric patients?	25
Demography and antibiotic susceptibility of emerging Chryseobacterium gleum among hospitalised patients in Malaysia	24
Efficacy of combination therapy with standard-dose carbapenem for treating nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii in intensive care units: A multicentre retrospect	24
Global evolutionary dynamics of virulence genes in ST11-KL47 carbapenem-resistant Klebsiella pneumoniae	24
Detection of mcr-1-harbouring Escherichia coli by quantum dot labelling of synthetic small peptides mimicking lipopolysaccharide receptors	24
Variability in oral antibiotic step-down therapy in the management of Gram-negative bloodstream infections	24
Cross-talk between signal transduction systems and metabolic networks in antibiotic resistance and tolerance	24
Flavonols interrupt internalized bacteria hijacking cellular responses via suppressing oxidative stress induced cellular apoptotic death	24
A Systematic Review of the Pharmacokinetics and Pharmacodynamics of Novel Beta-Lactams and Beta-Lactam with Beta-Lactamase Inhibitor Combinations for the Treatment of Pneumonia Caused by Carbapenem-Re	24
Silent dissemination of fosfomycin resistance genes in critical-priority Klebsiella pneumoniae	23
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	23
In reply to the Letter to the Editor regarding Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical Gram-negative bacillary meningitis or ventriculitis: A systematic review and	23
Characterization of the extended substrate spectrum of the class A β-lactamase CESS-1 from Stenotrophomonas sp. and structure-based investigation into its substrate preference	23
Comparing outcomes among outpatients treated for pyelonephritis with oral cephalosporins versus first-line agents	22
Impact of pre‐existent drug resistance on virological efficacy of single‐tablet regimens in people living with HIV	22
Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant	22
In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam:	22
MRSA surveillance programmes worldwide: moving towards a harmonised international approach	22
Population pharmacokinetics of levornidazole in healthy subjects and patients, and sequential dosing regimen proposal using pharmacokinetic/pharmacodynamic analysis	22
Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice	21
Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patients	21
Individualised amoxicillin-clavulanate dosing recommendations for critically ill children with augmented clearance after cardiac surgery	21
Machine learning accelerates the discovery of epitope-based dual-bioactive peptides against skin infections	21
Effectiveness of mRNA BNT162b2 and inactivated CoronaVac vaccines against severe COVID-19 outcomes among non-hospitalised children aged 1-3 years with SARS-CoV-2 Omicron infection	21
Aerosolized plus intravenous polymyxin B in comparison to intravenous polymyxin B alone for the management of HAP caused by carbapenem-resistant gram-negative bacteria: A prospective multicenter cohor	20
EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci	20
Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-ce	20
Microdialysis sampling to monitor target-site vancomycin concentrations in septic infants: a feasible way to close the knowledge gap	20
Alterins, a new family of marine antibacterial cyclolipopeptides	20
Metagenomic next-generation sequencing on treatment strategies and prognosis of patients with lower respiratory tract infections: A systematic review and meta-analysis	20
Proguanil and chlorhexidine augment the antibacterial activities of clarithromycin and rifampicin against Acinetobacter baumannii	20

Clinical and laboratory insights into the threat of hypervirulent Klebsiella pneumoniae	20
Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study	19
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance	19
Antimicrobial susceptibility and co-resistance among Pseudomonas aeruginosa isolates from hospital-acquired respiratory-tract infections: SMART 2017–2019 Malaysia	19
Longitudinal fluctuations of common antimicrobial resistance genes in the gut microbiomes of healthy Dutch individuals	19
Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae	19
Title Page & Editorial Board	19
Study on antibiotic resistance of Staphylococcus aureus isolated in Hue University hospital in 2018 and 2019	19
Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel	19
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases	19
PROGRAM-AT-A-GLANCE	19
Genomic characterization of vancomycin-resistant Enterococcus faecium transmission in hospital by whole genome sequencing	19
Eczematous skin colonization pattern with potential bacterial pathogens in paediatric population at a tertiary care setting, in Sri Lanka	19
Verapamil enhances the activity of Caspofungin against Cryptococcus neoformans， coinciding with inhibited Ca2+/CN pathway and damage to cell wall integrity	18
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	18
Shifting trends in bloodstream infection-causing microorganisms and their clinical impact in patients with haematologic malignancies in South Korea: A propensity score-matched study	18
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	18
Beware of resistance to 2nd-generation integrase inhibitors: A systematic meta-analysis of HIV-1 integrase inhibitors resistance and drug resistance mutations	18
Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy	18
Toxoplasma gondii infection or acute retinal necrosis in early stage: A case report	18
Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus	18
A review of recently discovered mechanisms of cephalosporin resistance in Pseudomonas aeruginosa	18
Global distribution of blaCMY-42, a gene mediating reduced susceptibility to aztreonam-avibactam and ceftazidime-avibactam, in Escherichia coli	18
Title Page & Editorial Board	18
Corrigendum to “Clinical and Economic Evaluation of Blood Culture Whole Process Optimisation in Critically Ill Adult Patients With Positive Blood Cultures” [International Journal of Antimicrobial Agen	18
Isavuconazole dosing in Asian patients with invasive mould infections: is there a role for therapeutic drug monitoring?	18
NDM-5-producing carbapenem-resistant Klebsiella pneumoniae of sequence type 789 emerged as a threat for neonates: a multicentre, genome-based study	18
Molecular investigation of an epidemic dissemination of vancomycin-resistant Enterococcus faecium sequence type 80 in Guangdong province, China	17
High diversity of blaNDM-1-encoding plasmids in Klebsiella pneumoniae isolated from neonates in a Vietnamese hospital	17
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing	17
Novel active Trp- and Arg-rich antimicrobial peptides with high solubility and low red blood cell toxicity designed using machine learning tools	17
Clinical outcomes of rifampicin combination therapy in implant-associated infections due to staphylococci and streptococci: A systematic review and meta-analysis	17
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based	17
The surveillance of colistin resistance and mobilized colistin resistance genes in multidrug-resistant Enterobacteriaceae isolated in Japan	17
Assessment of cefepime toxicodynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelines	17
The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)	16
Audit of empirical antibiotic therapy for sepsis and the impact of early multidisciplinary consultation on patient outcomes.	16
High concentrations of nirmatrelvir/ritonavir in critically ill patients receiving continuous renal replacement therapy	16
Corrigendum to “Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and	16
Plasma, intracellular and lymph node antiretroviral concentrations and HIV DNA change during primary HIV infection: Results from the INACTION P25 study	16
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	16
Tracking emergence and outbreak of Klebsiella pneumoniae co-producing NDM-1 and KPC-2 after sulfamethoxazole-trimethoprim treatment: Insights from genetic analysis	16
Mechanisms and fitness of ceftazidime/avibactam-resistant Klebsiella pneumoniae clinical strains in Taiwan	16
Intrapulmonary pharmacokinetics of high doses of tigecycline in patients with ventilator-associated pneumonia	16
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	16
What we learned from COVID-19 vaccination	15
Title Page & Editorial Board	15
Tigecycline heteroresistance and resistance mechanism in clinical isolates of Acinetobacter baumannii	15
High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial	15
Pharmacokinetic and preclinical safety studies of endolysin-based therapeutic for intravenous administration	15
In-silico identification of novel inhibitors for glutamate racemase (MurI) to decipher the subtle of antimicrobial resistance in Neisseria gonorrhoeae: A virtual screening and molecular dynamics appro	15
Nafcillin Augmentation of Daptomycin and Cathelicidin LL-37 Killing of Methicillin-resistant Staphylococcus epidermidis: Foundations of Successful Therapy of Endocarditis	15
Evaluation of tetracycline and fluoroquinolone therapy against Japanese spotted fever: Analysis based on individual data from case reports and case series	15
Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or continuous infusion	15
High-throughput mutagenesis and screening approach for the identification of drug-resistant mutations in the rifampicin resistance-determining region of mycobacteria	15
A case of atypical hemolytic uremic syndrome caused by Escherichia fergusonii mimicking Escherichia coli in an immunocompetent adult	15
Characteristic of Stenotrophomonas maltophilia antimicrobial profile in Malaysian isolates 2015–2020	15
Evaluation of synergistic activity of fosfomycin in combination with novel ß-lactams/ß-lactamase inhibitor combinations (βL-βLICs) against KPC-producing Klebsiella pneumoniae clinical isolates	15
Pleural penetration of amoxicillin and metronidazole during pleural infection: An ambispective cohort study	15
Human tissue distribution of caspofungin	15
Functional characterization and clinical implication of a novel epidemic carbapenem-resistant Acinetobacter baumannii genetic marker	14
Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials	14
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI	14
Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover cli	14
Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals	14
Safety of high loading doses of teicoplanin: POSY-TEICO, a prospective, multicentre, observational study	14
Respiratory fluoroquinolone monotherapy for community-acquired pneumonia: a revised trial sequential analysis	14
Rising threat of metallo-β-lactamase-producing Klebsiella oxytoca complex in Taiwan, 2013–2022	14
Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantification	14
Renal function and its impact on the concentration of ceftazidime-avibactam: A cross-sectional study	14
Pharmacodynamic and immunomodulatory effects of polymyxin B in combination with fosfomycin against KPC-2-producing Klebsiella pneumoniae	14
BPI23-Fcγ alleviates lethal multi-drug-resistant Acinetobacter baumannii infection by enhancing bactericidal activity and orchestrating neutrophil function	14
In-vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial	14
Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: A real-world, retrospective cohort study	14
Comparative efficacy and safety of systemic antifungal agents for candidemia: a systematic review with network meta-analysis and multicriteria acceptability analyses	13
Pharmacodynamics of ceftriaxone for the treatment of methicillin‐susceptible Staphylococcus aureus: is it a viable treatment option?	13
Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient	13
Con) Piperacillin-tazobactam for ESBL-producing Enterobacterales	13
Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: New data from CREDIBLE-CR with an updated meta-analysis	13
Intravenous to oral antibiotics versus intravenous antibiotics: a step-up or a step-down for extended spectrum β-lactamase (ESBL)-producing urinary tract infections without concomitant bacteraemia?	13

Pro) Piperacillin-tazobactam for ESBL-producing Enterobacterales	13
In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime/avibactam	13
High-level delafloxacin resistance through the combination of two different mechanisms in Staphylococcus aureus	13
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain	13
High prevalence of clonally related ST182 NDM-1-producing Enterobacter cloacae complex clinical isolates in Greece	13
How to combine novel techniques with stewardship: A real-world experience	13
Multicentre Clinical Evaluation of a Molecular Diagnostic Assay to Identify Neisseria gonorrhoeae Infection and Detect Antimicrobial Resistance	13
Genomic characterization of phenotypically carbapenem-resistant Escherichia coli isolates carrying unknown resistance genes in Malaysia	13
Persistence and dynamic structures of diverse cephalosporinase genes in nontyphoidal Salmonella in cross-sectional surveillance in Taiwan	13
Clinical efficacy of ceftazidime/avibactam combination therapy for severe hospital-acquired pulmonary infections caused by carbapenem-resistant and difficult-to-treat Pseudomonas aeruginosa	13
Optimal dosing regimen of biapenem based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation in patients with febrile neutropenia and haematological malignancies	13
Risk of Clostridioides difficile infection following different antibiotics: insights from multi-source medical data	13
Ferric chloride induces ferroptosis in Pseudomonas aeruginosa and heals wound infection in a mouse model	13
FL058, a novel β-lactamase inhibitor, increases the anti-Mycobacterium abscessus activity of imipenem	13
Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous venovenous haemodiafiltr	13
Optimising culture results of orthopaedic infections using blood culture bottles	13
Title Page & Editorial Board	12
Two natural compounds as potential inhibitors against the Helicobacter pylori and Acinetobacter baumannii IspD enzymes	12
IGRA-based INH regimen for prevention of active tuberculosis after kidney transplantation: A single-centre retrospective study	12
Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam	12
Susceptibility of Southeast Asian Plasmodium falciparum isolates to P218	12
Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience	12
New options for bloodstream infections caused by colistin‐ or ceftazidime/avibactam‐resistant Klebsiella pneumoniae	12
Sequential treatment effects on phage–antibiotic synergistic application against multi-drug-resistant Acinetobacter baumannii	12
A 22-year Brazilian colistin resistance surveillance on Escherichia coli and Salmonella spp. originating from food-producing animals	12
The Trifecta of Diagnostic Stewardship, Antimicrobial Stewardship, and Value Assessment of New Diagnostic Tests	12
Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the O	12
Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future	12
The dlt operon contributes to the resistance to chlorhexidine in Streptococcus mutans	12
In Vivo emergence of ceftazidime/avibactam, cefiderocol and aztreonam/avibactam cross-resistance in a patient with KPC-producing infection after cefiderocol-based treatment	12
Enhanced Endotoxin Release by Select Generic Meropenem Formulations in Pseudomonas aeruginosa	12
A novel indolylbenzoquinone compound HL-J6 suppresses biofilm formation and α-toxin secretion in methicillin-resistant Staphylococcus aureus	12
Clinical and laboratory factors in predicting mortality among SARS-CoV-2 RNA positive patients from a tertiary care center in South Tamilnadu – A retrospective observational study	12
Role of tcaA, a potential target as a ceftobiprole resistance breaker in MRSA β-lactam resistance	12
Reviewer Thank you List 2021	12
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	12
The antimicrobial activity of innate host-directed therapies: A systematic review	12
Strategies for quorum sensing inhibition as a tool for controlling Pseudomonas aeruginosa infections	12
Letter to the Editor: Comment to ‘Assessment of Dientamoeba fragilis interhuman transmission by faecal microbiota transplantation’ by Moreno-Sabater et al. (2025)	12
Access to phage therapy at Hospices Civils de Lyon in 2022: Implementation of the PHAGEinLYON Clinic programme	12
Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns	12
Cellular and genetic changes during and after fluconazole exposure in Cryptococcus neoformans	12
Long-term effects of ciprofloxacin treatment on the gastrointestinal and oropharyngeal microbiome are more pronounced after longer antibiotic courses	12
Clinical features and outcomes of vancomycin-resistant enterococcal meningitis in neonatal intensive care unit patients: presentation of three cases	12
The emergence of transposon-driven multidrug resistance in invasive nontypeable Haemophilus influenzae over the last decade	12
In vitro activities of ceftazidime–avibactam, ceftolozane–tazobactam, meropenem–vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Dat	11
In vitro activity of WCK 5222 (cefepime/zidebactam) against bioterror pathogen Burkholderia pseudomallei	11
Models for cytotoxicity screening of antileishmanial drugs: what has been done so far?	11
The evolution of carbapenem-resistant Pseudomonas aeruginosa in the COVID-19 era: A global perspective and regional insights	11
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity	11
Head-to-head comparison of multi-dose oritavancin and dalbavancin for complicated infections: A propensity score-matched analysis	11
Genetic alterations in methicillin-susceptible Staphylococcus aureus associated with high vancomycin minimum inhibitory concentration	11
Anti-Porphyromonas gingivalis nanotherapy for maintaining bacterial homeostasis in periodontitis	11
Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysis	11
Title Page & Editorial Board	11
Trial Sequential Analysis of Intrathecal/Intraventricular Antimicrobial Therapy for Post-Neurosurgical Gram-Negative Bacillary Meningitis or Ventriculitis	11
Investigating an outbreak of extensively drug-resistant Acinetobacter baumannii in a tertiary healthcare centre in lebanon using next-generation sequencing	11
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial	11
Resistance to aztreonam-avibactam among clinical isolates of Escherichia coli is primarily mediated by altered penicillin-binding protein 3 and impermeability	11
Plasma effects on bacterial time-kill dynamics: Insights from a PK/PD modelling analysis	11
A translational rat model to assess glomerular function changes with vancomycin	11
The epidemiology and clinical spectrum of melioidosis in a tertiary hospital in a north-eastern state of Malaysia: A three-year review	11
Molecular typification of Escherichia coli from community-acquired urinary tract infections in Mexico	11
Extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in humans and from food-producing animals in Italy: a ‘One Health’ study	11
In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020	11
Unveiling the clonal dynamics and transmission mechanism of carbapenem-resistant Klebsiella pneumoniae in the ICU environment	11
Population pharmacokinetics of nirmatrelvir in Chinese patients with COVID-19: Therapeutic drug monitoring and dosing regimen selection in clinical practice	10
Antimicrobial resistance profiles and molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli isolates from pigs in South Korea	10
Colistin-EDTA combination for eradication of colistin-resistant Klebsiella pneumoniae catheter related biofilm infections	10
Evaluation of deoxythymidine-based cationic amphiphiles as antimicrobial, antibiofilm, and anti-inflammatory agents	10
Pattern and appropriateness of antibiotic prescriptions for upper respiratory tract infections in primary care paediatric patients	10
Intestinal colonisation with hypervirulent or third-generation cephalosporin-resistant Klebsiella pneumoniae strains upon hospital admission in a general ward in Taiwan	10
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeabilit	10
Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae	10
Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study	10
Don’t bring home that bacon: a report of two simultaneous cases of Streptococcus suis meningitis	10
Phylogenetic insights of a human-derived optrA-positive Staphylococcus aureus isolated from a person with chronic diarrhea in China	10
Blockade of pan-viral propagation by inhibition of host cell PNPT1	10
Delivery of endolysin across outer membrane of Gram-negative bacteria using translocation domain of botulinum neurotoxin	10
Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics	10
MtrAB two-component system is crucial for the intrinsic resistance and virulence of Mycobacterium abscessus	10
Pro) Early oral transition for endocarditis	10
Meningitis caused by carbapenem resistant Enterobacter cloacae after endoscopic third ventriculostomy: A case report	10
Effect of achieving bone sterilisation on bone architecture and bone marrow, in an experimental rabbit model of osteomyelitis caused by carbapenemase-producing Enterobacterales	10
Indocyanine green clearance test as a predictor of linezolid overexposure in septic patients	10
Candida parapsilosis isolates carrying mutations outside FKS1 hotspot regions confer high echinocandin tolerance and facilitate the development of echinocandin resistance	10
Investigation of PhoP response regulator inhibition to overcome resistance in Gram-negative clinical bacteria	10
Clinical metagenomics for complicated skin and soft tissue infections	9
Small-molecule antiviral treatments for COVID-19: A systematic review and network meta-analysis	9
Activity of ceftolozane/tazobactam against gram-negative pathogens from pediatric patients in Asia/Pacific – SMART 2017–2019	9
A nation-wide multicentric study on community acquired urinary tract infection among children from a developing country	9
Controlling biofilm and virulence properties of Gram-positive bacteria by targeting wall teichoic acid and lipoteichoic acid	9
Title Page & Editorial Board	9
Efficacy of teicoplanin for bloodstream infection caused by Enterococcus faecium: a post-hoc analysis of a nationwide surveillance	9
Place of COVID-19 transmission in blood transmission: A case report	9